The Ph chromosome, a unique biomarker of CML, is a product of reciprocal translocation of the BCR gene on chromosome 22q11.2 and the ABL1 gene located on chromosome 9q34, and about 90–98% of CML patients harbor this mutation [105,177,178]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.